← All trials
NCT00084084
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2004
- Primary completion
- Jun 1, 2011
- Completion date
- Jun 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 17
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- ShireLead sponsor
- Tuscon Access Center of Arizona Kidney Disease Hypertension CenterOverall official - principal investigator
- Christus St. Patrick HospitalOverall official - principal investigator
- Baylor UniversityOverall official - principal investigator
- New York UniversityOverall official - principal investigator
- University of ArizonaOverall official - principal investigator
- University of TennesseeOverall official - principal investigator
- University of TorontoOverall official - principal investigator
- National Institutes of Health (NIH)Overall official - principal investigator
- Washington University in St. LouisOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.